Home » Access Biotechnology

Skip to content

FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

Search for:

Facebook
Twitter
Linkedin

Navigation

Site navigation

USA
UK
Germany
Canada
China
Russia
India
France
Italy
NFT

Home
Access Biotechnology

Access Biotechnology

Hemab Therapeutics

Denmark USA

Hemab Therapeutics Raises $135M in Series B Financing

Published on February 21, 2023February 21, 2023By FinSMEs

Matchpoint

USA

Matchpoint Therapeutics Raises $100M in Series A and Seed Funding

Published on October 17, 2022October 17, 2022By FinSMEs

USA

Acelyrin Raises $300M Series C Financing

Published on September 13, 2022September 13, 2022By FinSMEs

Upstream_logo

USA

Upstream Bio Raises $200M in Series A Financing

Published on June 2, 2022June 2, 2022By FinSMEs

Disc Medicine

USA

Disc Medicine Raises $90M in Series B Funding

Published on September 2, 2021September 2, 2021By FinSMEs

Eliem Therapeutics

UK USA

Eliem Therapeutics Launches with $80M in Financing

Published on April 2, 2021April 2, 2021By FinSMEs

dtx

USA

DTx Pharma Closes $100M Series B Financing

Published on March 5, 2021By FinSMEs

cancer

USA

Day One Biopharma Raises $60M in Series A Funding

Published on May 22, 2020May 22, 2020By FinSMEs

healthcare

USA

Pandion Therapeutics Closes $80M Series B Financing

Published on April 1, 2020April 1, 2020By FinSMEs

healthcare

USA

Disc Medicine Raises $50M in Series A Financing

Published on October 30, 2019By FinSMEs

trefoil

USA

Trefoil Therapeutics Raises $28M in Series A Funding

Published on July 16, 2019By FinSMEs

The Daily Deal Newsletter – Sign Up

Email address:

Leave this field empty if you're human:

About | Advertise | Contact | Terms & Conditions | Disclaimer | News | The Daily Deal Newsletter

Privacy Policy FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: [email protected]

Follow FinSMEs on:

Sign-up now to the Daily Newsletter